Search

Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

December 02, 2022, Medscape
How Blunt Is Too Blunt for Informed Consent?
David L. Feldman, MD, MBA, FACS, Chief Medical Officer for The Doctors Company and TDC Group, discusses the critical role of effective communication to ensure patient understanding in the informed consent process.

February 17, 2025, FDA Storm Proof: Plan for Every Possible Path
Disaster Preparedness for Your Dental Practice
Julie M. Brightwell, BSN, JD, RN, CPHRM, Director, Patient Safety, The Doctors Company, part of TDC Group, provides disaster preparedness recommendations for dental practices.

October 01, 2024, Cardiology Magazine
Misdiagnosis: Lessons Learned From a Cardiology Malpractice Case
This article, co-authored by Debra Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager for The Doctors Company, discusses how delayed diagnosis of myocardial infarction (MI) is a top malpractice allegation in cardiology.

Stay in the Know

Our e-newsletters feature timely articles, videos, and guides on a range of patient safety topics.

The Doctor’s Practice

Medical Icon Clipart Subscribe

The Dentist’s Advocate

Tooth Clipart Subscribe

The Practitioner

Man and Two Women Doctors Clipart Subscribe